IP Verse

Bayer Healthcare, Llc competitive analysis

Latest patents of Bayer Healthcare, Llc opposed by its competitors

Explore Bayer Healthcare, Llc's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3917493
Nov 5, 2025Topical Gel Compositions Of Naproxen1
EP4185318
Sep 3, 2025Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye Disorders10
EP1957110
Dec 23, 2020Process For Manufacturing Chewable Dosage Forms For Drug Delivery And Products Thereof1
EP2109394
May 23, 2018Analyte-Testing Device2
EP1447665
Jun 29, 2016Method For Reducing Effect Of Hematocrit On Measurement Of An Analyte In Whole Blood, And Test Kit And Test Article Useful In The Method1
EP1733043
Jun 1, 2016Method And Apparatus For Implementing Threshold Based Correction Functions For Biosensors1
EP2134251
Aug 13, 2014Meter Adapted To Simultaneously Display The Number Of High, Low And Total Test Results2

Latest PTAB cases involving Bayer Healthcare, Llc

Discover the latest PTAB cases involving Bayer Healthcare, Llc, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bayer Healthcare, Llc with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BAYER HEALTHCARE - 41 - 1
ABBOTT DIABETES CARE INC.2638179
ADVANZ PHARMA SERVICES UK5 - - -
AMGEN14163811